Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Diagnostic Tests16.54M92.27%
Biopharmaceutical Services and other1.39M7.73%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States49.09M100.00%